Presentation Information
[27-19-pm02]Evaluation of the validity of dose reduction criteria for edoxaban, a direct-acting oral anticoagulant, in clinical practice.
○Aimi Watanabe1, Daiki Hira1, Yuki Sato1, Sakiko Hatazoe2, Yugo Yamashita3, Hiroki Shiomi3, Keiko Ikuta1, Yurie Katsube1, Natsuki Imayoshi1, Satoshi Ueshima4, Masahiro Tsuda1,2, Shunsaku Nakagawa1, Koh Ono3, Tomohiro Terada1 (1. Department of Clinical Pharmacology and Therapeutics, Kyoto University Hospital., 2. Graduate School of Pharmaceutical Sciences, Kyoto University., 3. Department of Cardiovascular Medicine, Graduate School of Medicine, Kyoto University., 4. College of Pharmaceutical Sciences, Ritsumeikan University.)